Journal of Ophthalmology / 2015 / Article / Tab 2

Clinical Study

Effects of Lamellar Keratectomy and Intrastromal Injection of 0.2% Fluconazole on Fungal Keratitis

Table 2

Clinical characteristics of 8 failed cases.

PatientThe second
surgery
The max diameter
of lesion (mm)
The max depth
of lesion (%)
Fungus
identified
UCVABCVA

1LKT + CF4.0, 4.041.5, 37.3F. solani 20/60,
20/80
20/60,
20/60
2LKT + CF3.5, 3.530.6, 53.7F. solani FC/BE,
20/100
FC/BE,
20/80
3LKT + CF4.0, 4.549.2, 50.0NegativeFC/1.5 m,
20/60
FC/1.5 m,
20/60
4LKT + CF5.0, 5.046.5,49.5Negative20/125,
20/80
20/125,
20/80
5LKT + CF4.5, 5.043.5, 40.5F. solani 20/100,
20/80
20/100,
20/60
6LKP4.0, 5.045.0, 70.0A. versicolor 20/200,
20/160,
20/80
20/200,
20/160,
20/60
7LKP5.0, 5.540.2, 63.0A. flavus 20/200,
20/100,
20/100
20/100,
20/100,
20/80
8PKP4.5, 5.039.4, 92.6A. fumigatus FC/1 m,
20/200,
20/60
FC/1 m,
20/100,
20/40

The clinical features before the first and the second surgery (first, second).
BCVA values are before the first surgery and 90 days after the second surgery and when followed up for 1 year in the keratoplasty cases (first, second).
LKT + CF, lamellar keratectomy and inlay conjunctival flap; LKP, lamellar keratoplasty; PKP, penetrating keratoplasty; FC, finger count; BE, before eye.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.